Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride succinate for gastrointestinal motility after laparoscopic gastrectomy
NCT05966246Completed
- Sponsor
- Gangnam Severance Hospital
- Start
- Jan 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of prucalopride in postoperative ileus (POI), sponsored by Gangnam Severance Hospital. Primary endpoint: Quantitative intestinal motility measurement using radio-opaque markers at Day 5. Started Jan 2022; status: completed.
02
Drugs
prucalopride
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT05966246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05966246.